1. Ивашкин В.Т. Горизонты клинической гастроэнтерологии. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 1993(1): 6 - 12,

2. Clain J.E., Pearson R.K. Diagnosis of chronic pancreatitis. Is a gold standard necessary? Surg Clin North Am. 1999; 79(4): 829 - 45, http://www.ncbi.nlm.nih.gov/pubmed/10470330

3. Ивашкин В.Т., Шифрин О.С., Соколина И.А. Хронический панкреатит, стеатоз поджелудочной железы и стеатопанкреатит: ЛитТерра; 2014.

4. Whitcomb D.C., Frulloni L., Garg P., Greer J.B., Schneider A., Yadav D., et al. Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016; 16(2): 218 - 24. doi: 10.1016/j.pan.2016.02.001

5. Etemad B., Whitcomb D.C. Chronic Pancreatitis: Diagnosis, Classification, and New Genetic Developments. Gastroenterology. 2001; 120(3): 682 - 707. doi: 10.1053/gast.2001.22586

6. Whitcomb D.C., North American Pancreatitis Study G. Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist With Topic Reviews, Updates, and Use Primers. Clin Transl Gastroenterol. 2019; 10(6): e00027. doi: 10.14309/ctg.0000000000000027

7. Григорьева И.Н., Никитенко Т.М., Ямлиханова А.Ю., Максимов В.Н., Мироненко Т.В., Воевода М.И. Алкогольный панкреатит: гендерные, возрастные, генетические особенности. Бюллетень Сибирского отделения Российской академии медицинских наук. 2009(3): 42 - 7,

8. Conwell D.L., Banks P.A., Sandhu B.S., Sherman S., Al-Kaade S., Gardner T.B., et al. Validation of Demographics, Etiology, and Risk Factors for Chronic Pancreatitis in the USA: A Report of the North American Pancreas Study (NAPS) Group. Dig Dis Sci. 2017; 62(8): 2133 - 40. doi: 10.1007/s10620-017-4621-z

9. Andriulli A., Botteri E., Almasio P.L., Vantini I., Uomo G., Maisonneuve P., et al. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas. 2010; 39(8): 1205 - 10. doi: 10.1097/MPA.0b013e3181df27c0

10. Lugea A., Gerloff A., Su H.Y., Xu Z., Go A., Hu C., et al. The Combination of Alcohol and Cigarette Smoke Induces Endoplasmic Reticulum Stress and Cell Death in Pancreatic Acinar Cells. Gastroenterology. 2017; 153(6): 1674 - 86. doi: 10.1053/j.gastro.2017.08.036

11. Cote G.A., Yadav D., Slivka A., Hawes R.H., Anderson M.A., Burton F.R., et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2011; 9(3): 266 - 73; quiz e27. doi: 10.1016/j.cgh.2010.10.015

12. Chung E.K., Lee J.H., Jang D.K., Lee S.H., Lee J.H., Park B.J., et al. Causative Agents of Drug-Induced Pancreatitis: A Nationwide Assessment. Pancreas. 2018; 47(10): 1328 - 36. doi: 10.1097/MPA.0000000000001152

13. Chadalavada P., Simons-Linares C.R., Chahal P. Drug-induced acute pancreatitis: Prevalence, Causative agents, and Outcomes. Pancreatology. 2020; 20(7): 1281 - 6. doi: 10.1016/j.pan.2020.07.401

14. Bai H.X., Giefer M., Patel M., Orabi A.I., Husain S.Z. The association of primary hyperparathyroidism with pancreatitis. J Clin Gastroenterol. 2012; 46(8): 656 - 61. doi: 10.1097/MCG.0b013e31825c446c

15. Misgar R.A., Bhat M.H., Rather T.A., Masoodi S.R., Wani A.I., Bashir M.I., et al. Primary hyperparathyroidism and pancreatitis. J Endocrinol Invest. 2020; 43(10): 1493 - 8. doi: 10.1007/s40618-020-01233-5

16. Gao Y., Yu C., Xiang F., Xie M., Fang L. Acute pancreatitis as an initial manifestation of parathyroid carcinoma: A case report and literature review. Medicine (Baltimore). 2017; 96(44): e8420. doi: 10.1097/MD.0000000000008420

17. Gorvin C.M., Frost M., Malinauskas T., Cranston T., Boon H., Siebold C., et al. Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias. Hum Mol Genet. 2018; 27(21): 3720 - 33. doi: 10.1093/hmg/ddy263

18. Setiawan V.W., Pandol S.J., Porcel J., Wei P.C., Wilkens L.R., Le Marchand L., et al. Dietary Factors Reduce Risk of Acute Pancreatitis in a Large Multiethnic Cohort. Clin Gastroenterol Hepatol. 2017; 15(2): 257 - 65 e3. doi: 10.1016/j.cgh.2016.08.038

19. Xiao A.Y., Tan M.L., Wu L.M., Asrani V.M., Windsor J.A., Yadav D., et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016; 1(1): 45 - 55. doi: 10.1016/S2468-1253(16)30004-8

20. Wu B.U., Batech M., Dong E.Y., Duan L., Yadav D., Chen W. Influence of Ambulatory Triglyceride Levels on Risk of Recurrence in Patients with Hypertriglyceridemic Pancreatitis. Dig Dis Sci. 2019; 64(3): 890 - 7. doi: 10.1007/s10620-018-5226-x

21. Pedersen S.B., Langsted A., Nordestgaard B.G. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis. JAMA Intern Med. 2016; 176(12): 1834 - 42. doi: 10.1001/jamainternmed.2016.6875

22. Mohapatra S., Majumder S., Smyrk T.C., Zhang L., Matveyenko A., Kudva Y.C., et al. Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature. Pancreas. 2016; 45(8): 1104 - 10. doi: 10.1097/MPA.0000000000000609

23. Aune D., Mahamat-Saleh Y., Norat T., Riboli E. Diabetes mellitus and the risk of pancreatitis: A systematic review and meta-analysis of cohort studies. Pancreatology. 2020; 20(4): 602 - 7. doi: 10.1016/j.pan.2020.03.019

24. Whitcomb D.C., Gorry M.C., Preston R.A., Furey W., Sossenheimer M.J., Ulrich C.D., et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996; 14(2): 141 - 5. doi: 10.1038/ng1096-141

25. Kahraman S., Dirice E., Basile G., Diegisser D., Alam J., Johansson B.B., et al. Abnormal exocrine-endocrine cell cross-talk promotes beta-cell dysfunction and loss in MODY8. Nat Metab. 2022; 4(1): 76 - 89. doi: 10.1038/s42255-021-00516-2

26. Sharer N., Schwarz M., Malone G., Howarth A., Painter J., Super M., et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998; 339(10): 645 - 52. doi: 10.1056/NEJM199809033391001

27. Ohmuraya M., Yamamura K. Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases. Exp Anim. 2011; 60(5): 433 - 44, http://www.ncbi.nlm.nih.gov/pubmed/22041280

28. Кучерявый Ю.А., Петрова Н.В., Тибилова З.Ф. Мутации гена панкреатического секреторного ингибитора трипсина N34S у больных хроническим идиопатическим панкреатитом Экспериментальная и клиническая гастроэнтерология. 2011(7): 7 - 12,

29. Di Leo M., Bianco M., Zuppardo R.A., Guslandi M., Calabrese F., Mannucci A., et al. Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update. Dig Liver Dis. 2017; 49(8): 847 - 53. doi: 10.1016/j.dld.2017.04.023

30. Kager L.M., Lekkerkerker S.J., Arvanitakis M., Delhaye M., Fockens P., Boermeester M.A., et al. Outcomes After Conservative, Endoscopic, and Surgical Treatment of Groove Pancreatitis: A Systematic Review. J Clin Gastroenterol. 2017; 51(8): 749 - 54. doi: 10.1097/MCG.0000000000000746

31. Кучерявый Ю.А., Оганесян Т.С. Аутоиммунный панкреатит: алгоритмы диагностики и подходы к лечению. Клинические перспективы гастроэнтерологии, гепатологии. 2010(6): 3 - 10,

32. Охлобыстин А.В. Аутоиммунный панкреатит: новые представления о патогенезе, диагностике и лечении. Доказат гастроэнтерол. 2013(1): 22 - 7,

33. Shimosegawa T., Chari S.T., Frulloni L., Kamisawa T., Kawa S., Mino-Kenudson M., et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011; 40(3): 352 - 8. doi: 10.1097/MPA.0b013e3182142fd2

34. Machicado J.D., Yadav D. Epidemiology of Recurrent Acute and Chronic Pancreatitis: Similarities and Differences. Dig Dis Sci. 2017; 62(7): 1683 - 91. doi: 10.1007/s10620-017-4510-5

35. Sankaran S.J., Xiao A.Y., Wu L.M., Windsor J.A., Forsmark C.E., Petrov M.S. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology. 2015; 149(6): 1490 - 500 e1. doi: 10.1053/j.gastro.2015.07.066

36. Ahmed Ali U., Issa Y., Hagenaars J.C., Bakker O.J., van Goor H., Nieuwenhuijs V.B., et al. Risk of Recurrent Pancreatitis and Progression to Chronic Pancreatitis After a First Episode of Acute Pancreatitis. Clin Gastroenterol Hepatol. 2016; 14(5): 738 - 46. doi: 10.1016/j.cgh.2015.12.040

37. Shah I., Bocchino R., Ahmed A., Freedman S.D., Kothari D.J., Sheth S.G. Impact of recurrent acute pancreatitis on the natural history and progression to chronic pancreatitis. Pancreatology. 2022; 22(8): 1084 - 90. doi: 10.1016/j.pan.2022.09.237

38. Маев И.В., Кучерявый Ю.А. Болезни поджелудочной железы. В 2-х томах. Москва: ОАО "Издательство "Медицина", издательство "Шико"; 2008. 976 p.

39. Petrov M.S., Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019; 16(3): 175 - 84. doi: 10.1038/s41575-018-0087-5

40. Ouyang G., Pan G., Liu Q., Wu Y., Liu Z., Lu W., et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990 - 2017: a systematic analysis for the Global Burden of Disease Study 2017. BMC Med. 2020; 18(1): 388. doi: 10.1186/s12916-020-01859-5

41. Shimizu K., Shiratori K. [Chronic pancreatitis. 1. Its epidemiology and symptoms]. Nihon Naika Gakkai Zasshi. 2010; 99(1): 36 - 40, http://www.ncbi.nlm.nih.gov/pubmed/20373578

42. Ивашкин В.Т., Хазанов А.И., Пискунов Г.Г., Ивлев А.С., Селезнев Ю.К., Никитин В.Г. О классификации хронического панкреатита. Клиническая медицина. 1990; 68(10): 96 - 9, http://www.ncbi.nlm.nih.gov/pubmed/2077297

43. Warshaw A.L., Banks P.A., Fernandez-Del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology. 1998; 115(3): 765 - 76, http://www.ncbi.nlm.nih.gov/pubmed/9721175

44. Ammann R.W., Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology. 1999; 116(5): 1132 - 40, http://www.ncbi.nlm.nih.gov/pubmed/10220505

45. Hollemans R.A., Hallensleben N.D.L., Mager D.J., Kelder J.C., Besselink M.G., Bruno M.J., et al. Pancreatic exocrine insufficiency following acute pancreatitis: Systematic review and study level meta-analysis. Pancreatology. 2018; 18(3): 253 - 62. doi: 10.1016/j.pan.2018.02.009

46. Ahmed S.A., Wray C., Rilo H.L., Choe K.A., Gelrud A., Howington J.A., et al. Chronic pancreatitis: recent advances and ongoing challenges. Curr Probl Surg. 2006; 43(3): 127 - 238. doi: 10.1067/j.cpsurg.2005.12.005

47. Zhu X., Liu D., Wei Q., Lin H., Zhi M., Chen Y., et al. New-Onset Diabetes Mellitus After Chronic Pancreatitis Diagnosis: A Systematic Review and Meta-analysis. Pancreas. 2019; 48(7): 868 - 75. doi: 10.1097/MPA.0000000000001359

48. Hart P.A., Bellin M.D., Andersen D.K., Bradley D., Cruz-Monserrate Z., Forsmark C.E., et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016; 1(3): 226 - 37. doi: 10.1016/S2468-1253(16)30106-6

49. Bornman P.C., Botha J.F., Ramos J.M., Smith M.D., Van der Merwe S., Watermeyer G.A., et al. Guideline for the diagnosis and treatment of chronic pancreatitis. S Afr Med J. 2010; 100(12 Pt 2): 845 - 60, http://www.ncbi.nlm.nih.gov/pubmed/21414280

50. Cui Y., Andersen D.K. Pancreatogenic diabetes: special considerations for management. Pancreatology. 2011; 11(3): 279 - 94. doi: 10.1159/000329188

51. Lankisch P.G. Natural course of chronic pancreatitis. Pancreatology. 2001; 1(1): 3 - 14. doi: 10.1159/000055786

52. Yeo C.J., Bastidas J.A., Lynch-Nyhan A., Fishman E.K., Zinner M.J., Cameron J.L. The natural history of pancreatic pseudocysts documented by computed tomography. Surg Gynecol Obstet. 1990; 170(5): 411 - 7, http://www.ncbi.nlm.nih.gov/pubmed/2326721

53. Gouyon B., Levy P., Ruszniewski P., Zins M., Hammel P., Vilgrain V., et al. Predictive factors in the outcome of pseudocysts complicating alcoholic chronic pancreatitis. Gut. 1997; 41(6): 821 - 5, http://www.ncbi.nlm.nih.gov/pubmed/9462217

54. Li Z.R., Cao D., Li J., Yang H., Han X.L., Xue H.D., et al. [Clinical Features and Outcomes of Paraduodenal Pancreatitis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018; 40(3): 328 - 33. doi: 10.3881/j.issn.1000-503X.2018.03.005

55. Larjani S., Bruckschwaiger V.R., Stephens L.A., James P.D., Martel G., Mimeault R., et al. Paraduodenal pancreatitis as an uncommon cause of gastric outlet obstruction: A case report and review of the literature. Int J Surg Case Rep. 2017; 39: 14 - 8. doi: 10.1016/j.ijscr.2017.07.043

56. Барванян Г.М. Хирургическая тактика при хроническом панкреатите, осложненном обструкцией желчных путей и двенадцатиперстной кишки. Хирургия Журнал им НИ Пирогова. 2016(11): 33 - 7. doi: 10.17116/hirurgia20161133-37

57. Kleeff J., Whitcomb D.C., Shimosegawa T., Esposito I., Lerch M.M., Gress T., et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017; 3: 17060. doi: 10.1038/nrdp.2017.60

58. Conwell D.L., Lee L.S., Yadav D., Longnecker D.S., Miller F.H., Mortele K.J., et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014; 43(8): 1143 - 62. doi: 10.1097/MPA.0000000000000237

59. Spanier B.W., Dijkgraaf M.G., Bruno M.J. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update. Best Pract Res Clin Gastroenterol. 2008; 22(1): 45 - 63. doi: 10.1016/j.bpg.2007.10.007

60. Latorre Fragua R.A., Manuel Vazquez A., Lopez Marcano A.J., Gijon De La Santa L., de la Plaza Llamas R., Ramia Angel J.M. Pancreatic Surgery in Chronic Pancreatitis Complicated by Extrahepatic Portal Hypertension or Cavernous Transformation of the Portal Vein: A Systematic Review. Scand J Surg. 2019: 1457496919857260. doi: 10.1177/1457496919857260

61. Кубышкин В.А., Кригер А.Г., Цыганков В.Н., Варава А.Б. Лечение больных хроническим панкреатитом, осложненным ложными аневризмами артерий бассейна чревного ствола и верхней брыжеечной артерии. Вестник экспериментальной и клинической хирургии. 2012; V(1): 12 - 21,

62. Haaber A.B., Rosenfalck A.M., Hansen B., Hilsted J., Larsen S. Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int J Pancreatol. 2000; 27(1): 21 - 7. doi: 10.1385/IJGC:27:1:21

63. Lindkvist B., Dominguez-Munoz J.E., Luaces-Regueira M., Castineiras-Alvarino M., Nieto-Garcia L., Iglesias-Garcia J. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012; 12(4): 305 - 10. doi: 10.1016/j.pan.2012.04.006

64. Martinez-Moneo E., Stigliano S., Hedstrom A., Kaczka A., Malvik M., Waldthaler A., et al. Deficiency of fat-soluble vitamins in chronic pancreatitis: A systematic review and meta-analysis. Pancreatology. 2016; 16(6): 988 - 94. doi: 10.1016/j.pan.2016.09.008

65. Hoogenboom S.A., Lekkerkerker S.J., Fockens P., Boermeester M.A., van Hooft J.E. Systematic review and meta-analysis on the prevalence of vitamin D deficiency in patients with chronic pancreatitis. Pancreatology. 2016; 16(5): 800 - 6. doi: 10.1016/j.pan.2016.07.010

66. Ивашкин В.Т., Маев И.В., Абдулганиева Д.И., Алексеева О.П., Алексеенко С.А., Зольникова О.Ю., et al. Практические рекомендации Научного сообщества по содействию клиническому изучению микробиома человека (НСОИМ) и Российской гастроэнтерологической ассоциации (РГА) по диагностике и лечению синдрома избыточного бактериального роста у взрослых. Рос журн гастроэнтерол гепатол колопроктол. 2022; 32(3): 68 - 85. doi: 10.22416/1382-4376-2022-32-3-68-85

67. El Kurdi B., Babar S., El Iskandarani M., Bataineh A., Lerch M.M., Young M., et al. Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression. Clin Transl Gastroenterol. 2019; 10(9): e00072. doi: 10.14309/ctg.0000000000000072

68. Grace E., Shaw C., Whelan K., Andreyev H.J. Review article: small intestinal bacterial overgrowth - prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther. 2013; 38(7): 674 - 88. doi: 10.1111/apt.12456

69. Efremova I., Maslennikov R., Poluektova E., Vasilieva E., Zharikov Y., Suslov A., et al. Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023; 29(22): 3400 - 21. doi: 10.3748/wjg.v29.i22.3400

70. Kamisawa T., Tu Y., Egawa N., Nakajima H., Tsuruta K., Okamoto A. The incidence of pancreatic and extrapancreatic cancers in Japanese patients with chronic pancreatitis. Hepatogastroenterology. 2007; 54(77): 1579 - 81, http://www.ncbi.nlm.nih.gov/pubmed/17708304

71. Thuluvath P.J., Imperio D., Nair S., Cameron J.L. Chronic pancreatitis. Long-term pain relief with or without surgery, cancer risk, and mortality. J Clin Gastroenterol. 2003; 36(2): 159 - 65, http://www.ncbi.nlm.nih.gov/pubmed/12544201

72. Kirkegard J., Mortensen F.V., Cronin-Fenton D. Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis. Am J Gastroenterol. 2017; 112(9): 1366 - 72. doi: 10.1038/ajg.2017.218

73. Olesen S.S., Krarup H., Poulsen J.L., Christensen J.H., Sheel A.R.G., Sutton R., et al. Pancreas-specific plasma amylase for assessment and diagnosis of chronic pancreatitis: New insights on an old topic. United European Gastroenterol J. 2019; 7(7): 955 - 64. doi: 10.1177/2050640619846011

74. Oh H.C., Kwon C.I., El H., II, Easler J.J., Watkins J., Fogel E.L., et al. Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis. Gut Liver. 2017; 11(6): 878 - 83. doi: 10.5009/gnl17066

75. Pezzilli R., Melzi d"Eril G., Barassi A. Can Serum Pancreatic Amylase and Lipase Levels Be Used as Diagnostic Markers to Distinguish Between Patients With Mucinous Cystic Lesions of the Pancreas, Chronic Pancreatitis, and Pancreatic Ductal Adenocarcinoma? Pancreas. 2016; 45(9): 1272 - 5. doi: 10.1097/MPA.0000000000000638

76. Benini L., Amodio A., Campagnola P., Agugiaro F., Cristofori C., Micciolo R., et al. Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. Pancreatology. 2013; 13(1): 38 - 42. doi: 10.1016/j.pan.2012.11.307

77. Siegmund E., Lohr J.M., Schuff-Werner P. [The diagnostic validity of non-invasive pancreatic function tests - a meta-analysis]. Z Gastroenterol. 2004; 42(10): 1117 - 28. doi: 10.1055/s-2004-813604

78. Dominguez-Munoz J.E., P D.H., Lerch M.M., Lohr M.J. Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. Dig Dis Sci. 2017; 62(5): 1119 - 30. doi: 10.1007/s10620-017-4524-z

79. Vanga R.R., Tansel A., Sidiq S., El-Serag H.B., Othman M.O. Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018; 16(8): 1220 - 8 e4. doi: 10.1016/j.cgh.2018.01.027

80. Dominguez-Munoz J.E., Iglesias-Garcia J., Vilarino-Insua M., Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2007; 5(4): 484 - 8. doi: 10.1016/j.cgh.2007.01.004

81. Gullo L., Ventrucci M., Tomassetti P., Migliori M., Pezzilli R. Fecal elastase 1 determination in chronic pancreatitis. Dig Dis Sci. 1999; 44(1): 210 - 3, http://www.ncbi.nlm.nih.gov/pubmed/9952246

82. Khan A., Vege S.S., Dudeja V., Chari S.T. Staging exocrine pancreatic dysfunction. Pancreatology. 2022; 22(1): 168 - 72. doi: 10.1016/j.pan.2021.11.005

83. Olson D.E., Rhee M.K., Herrick K., Ziemer D.C., Twombly J.G., Phillips L.S. Screening for diabetes and pre-diabetes with proposed AlC-based diagnostic criteria. Diabetes Care. 2010; 33(10): 2184 - 9. doi: 10.2337/dc10-0433

84. Hoffmeister A., Mayerle J., Beglinger C., Buchler M.W., Bufler P., Dathe K., et al. [S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol. 2012; 50(11): 1176 - 224. doi: 10.1055/s-0032-1325479

85. Glasbrenner B., Kahl S., Malfertheiner P. Modern diagnostics of chronic pancreatitis. Eur J Gastroenterol Hepatol. 2002; 14(9): 935 - 41. doi: 10.1097/00042737-200209000-00003

86. Gardner T.B., Adler D.G., Forsmark C.E., Sauer B.G., Taylor J.R., Whitcomb D.C. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol. 2020; 115(3): 322 - 39. doi: 10.14309/ajg.0000000000000535

87. James O., Agnew J.E., Bouchier I.A. Chronic pancreatitis in England: a changing picture? Br Med J. 1974; 2(5909): 34 - 8, http://www.ncbi.nlm.nih.gov/pubmed/4821040

88. Issa Y., Kempeneers M.A., van Santvoort H.C., Bollen T.L., Bipat S., Boermeester M.A. Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis. Eur Radiol. 2017; 27(9): 3820 - 44. doi: 10.1007/s00330-016-4720-9

89. Badea R., Diaconu B. Contribution of ultrasound to the diagnosis of chronic pancreatitis and to evaluating its main complications. Rom J Gastroenterol. 2005; 14(2): 183 - 9, http://www.ncbi.nlm.nih.gov/pubmed/15990941

90. Friess H., Kleeff J., Buchler M.W. Molecular pathophysiology of chronic pancreatitis - an update. J Gastrointest Surg. 2003; 7(8): 943 - 5. doi: 10.1016/j.gassur.2003.10.002

91. Frulloni L., Falconi M., Gabbrielli A., Gaia E., Graziani R., Pezzilli R., et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 2010; 42 Suppl 6: S381 - 406. doi: 10.1016/S1590-8658(10)60682-2

92. Dimcevski G., Erchinger F.G., Havre R., Gilja O.H. Ultrasonography in diagnosing chronic pancreatitis: new aspects. World J Gastroenterol. 2013; 19(42): 7247 - 57. doi: 10.3748/wjg.v19.i42.7247

93. Engjom T., Sangnes D.A., Havre R.F., Erchinger F., Pham K.D., Haldorsen I.S., et al. Diagnostic Accuracy of Transabdominal Ultrasound in Chronic Pancreatitis. Ultrasound Med Biol. 2017; 43(4): 735 - 43. doi: 10.1016/j.ultrasmedbio.2016.11.020

94. Kalra M.K., Maher M.M., Sahani D.V., Digmurthy S., Saini S. Current status of imaging in pancreatic diseases. J Comput Assist Tomogr. 2002; 26(5): 661 - 75, http://www.ncbi.nlm.nih.gov/pubmed/12439296

95. Okhlobystin A. Aetiology and diagnosis of chronic pancreatitis. In: Lohr J-M, Vujasinovic M, editors. A primer in pancreas. Karolinska universitetssjukhuset: ME buk; 2023. p. 44 - 9.

96. Shimizu K., Ito T., Irisawa A., Ohtsuka T., Ohara H., Kanno A., et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2021. J Gastroenterol. 2022; 57(10): 709 - 24. doi: 10.1007/s00535-022-01911-6

97. Леушина Е.А., editor Использование компьютерной томографии в диагностике осложнений хронического панкреатита. Инновационная наука в современном мире 2022 08 июня 2022 года; Минск. Нефтекамск: Научно-издательский центр "Мир науки" (ИП Вострецов Александр Ильич); 2022.

98. Lankisch P.G. Diagnosis of chronic pancreatitis. Lancet. 1998; 351(9102): 599 - 600. doi: 10.1016/S0140-6736(05)78589-5

99. Ивашкин В.Т., Шифрин О.С., Соколина И.А. Хронический панкреатит и стеатоз поджелудочной железы: ЛитТерра; 2012.

100. Catalano M.F., Linder J.D., George S., Alcocer E., Geenen J.E. Treatment of symptomatic distal common bile duct stenosis secondary to chronic pancreatitis: comparison of single vs. multiple simultaneous stents. Gastrointest Endosc. 2004; 60(6): 945 - 52, http://www.ncbi.nlm.nih.gov/pubmed/15605010

101. Catalano M.F., Sahai A., Levy M., Romagnuolo J., Wiersema M., Brugge W., et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009; 69(7): 1251 - 61. doi: 10.1016/j.gie.2008.07.043

102. Jacobson B.C., Baron T.H., Adler D.G., Davila R.E., Egan J., Hirota W.K., et al. ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc. 2005; 61(3): 363 - 70. doi: 10.1016/s0016-5107(04)02779-8

103. Anaizi A., Hart P.A., Conwell D.L. Diagnosing Chronic Pancreatitis. Dig Dis Sci. 2017; 62(7): 1713 - 20. doi: 10.1007/s10620-017-4493-2

104. Iglesias-Garcia J., Dominguez-Munoz J.E., Castineira-Alvarino M., Luaces-Regueira M., Larino-Noia J. Quantitative elastography associated with endoscopic ultrasound for the diagnosis of chronic pancreatitis. Endoscopy. 2013; 45(10): 781 - 8. doi: 10.1055/s-0033-1344614

105. Morris-Stiff G., Webster P., Frost B., Lewis W.G., Puntis M.C., Roberts S.A. Endoscopic ultrasound reliably identifies chronic pancreatitis when other imaging modalities have been non-diagnostic. JOP. 2009; 10(3): 280-3, http://www.ncbi.nlm.nih.gov/pubmed/19454820

106. Mortele K.J., Rocha T.C., Streeter J.L., Taylor A.J. Multimodality imaging of pancreatic and biliary congenital anomalies. Radiographics. 2006; 26(3): 715 - 31. doi: 10.1148/rg.263055164

107. Tirkes T., Yadav D., Conwell D.L., Territo P.R., Zhao X., Venkatesh S.K., et al. Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. Abdom Radiol (NY). 2019; 44(8): 2809 - 21. doi: 10.1007/s00261-019-02049-5

108. Yasokawa K., Ito K., Kanki A., Yamamoto A., Torigoe T., Sato T., et al. Evaluation of pancreatic exocrine insufficiency by cine-dynamic MRCP using spatially selective inversion-recovery (IR) pulse: Correlation with severity of chronic pancreatitis based on morphological changes of pancreatic duct. Magn Reson Imaging. 2018; 48: 70 - 3. doi: 10.1016/j.mri.2017.12.007

109. Trikudanathan G., Walker S.P., Munigala S., Spilseth B., Malli A., Han Y., et al. Diagnostic Performance of Contrast-Enhanced MRI With Secretin-Stimulated MRCP for Non-Calcific Chronic Pancreatitis: A Comparison With Histopathology. Am J Gastroenterol. 2015; 110(11): 1598 - 606. doi: 10.1038/ajg.2015.297

110. Tirkes T., Fogel E.L., Sherman S., Lin C., Swensson J., Akisik F., et al. Detection of exocrine dysfunction by MRI in patients with early chronic pancreatitis. Abdom Radiol (NY). 2017; 42(2): 544 - 51. doi: 10.1007/s00261-016-0917-2

111. Zhao X., Cui N., Wang X., Cui Y. Surgical strategies in the treatment of chronic pancreatitis: An updated systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017; 96(9): e6220. doi: 10.1097/MD.0000000000006220

112. Хатьков И.Е., Маев И.В., Абдулхаков С.Р., Алексеенко С.А., Алиева Э.И., Алиханов Р.Б., et al. Российский консенсус по диагностике и лечению хронического панкреатита. Терапевтический архив (архив до 2018 г). 2017; 89(2): 105 - 13. doi: https://doi.org/10.17116/terarkh2017892105-113

113. Zator Z., Whitcomb D.C. Insights into the genetic risk factors for the development of pancreatic disease. Therap Adv Gastroenterol. 2017; 10(3): 323 - 36. doi: 10.1177/1756283X16684687

114. Kinney T.P., Punjabi G., Freeman M. Technology insight: applications of MRI for the evaluation of benign disease of the pancreas. Nat Clin Pract Gastroenterol Hepatol. 2007; 4(3): 148 - 59. doi: 10.1038/ncpgasthep0760

115. Matos C., Metens T., Deviere J., Nicaise N., Braude P., Van Yperen G., et al. Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology. 1997; 203(2): 435 - 41, http://www.ncbi.nlm.nih.gov/pubmed/9114101

116. Dai C., Cao Q., Jiang M., Sun M.J. Serum Immunoglobulin G4 in Discriminating Autoimmune Pancreatitis From Pancreatic Cancer: A Diagnostic Meta-analysis. Pancreas. 2018; 47(3): 280 - 4. doi: 10.1097/MPA.0000000000000994

117. Lian M.J., Liu S., Wu G.Y., Liu S.Y. Serum IgG4 and IgG for the diagnosis of autoimmune pancreatitis: A systematic review with meta-analysis. Clin Res Hepatol Gastroenterol. 2016; 40(1): 99 - 109. doi: 10.1016/j.clinre.2015.06.002

118. Ghazale A., Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007; 102(8): 1646 - 53. doi: 10.1111/j.1572-0241.2007.01264.x

119. Lohr J.M., Beuers U., Vujasinovic M., Alvaro D., Frokjaer J.B., Buttgereit F., et al. European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J. 2020; 8(6): 637 - 66. doi: 10.1177/2050640620934911

120. Okazaki K., Kawa S., Kamisawa T., Ikeura T., Itoi T., Ito T., et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020. J Gastroenterol. 2022; 57(4): 225 - 45. doi: 10.1007/s00535-022-01857-9

121. Кучерявый Ю.А., Маев И.В., Москалева А.Б., Сайдуллаева М.Г., Цуканов В.В., Джаватханова Р.Т., et al. Влияние нутритивного статуса на течение хронического панкреатита. 2012(2): 100 - 4,

122. Кучерявый Ю.А., Москалева А.Б., Свиридова А.В. Нутритивный статус как фактор риска осложнений хронического панкреатита и развития панкреатической недостаточности. Экспериментальная и клиническая гастроэнтерология. 2012(7): 10 - 6,

123. Маев И.В., Андреев Д.Н., Кучерявый Ю.А., Левченко А.И. Распространенность саркопении у пациентов с хроническим панкреатитом: метаанализ. Тер архив. 2020; 92(12): 43 - 7. doi: 10.26442/00403660.2020.12.200430

124. Pimentel M., Saad R.J., Long M.D., Rao S.S.C. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020; 115(2): 165 - 78. doi: 10.14309/ajg.0000000000000501

125. Бордин Д.С., Винокурова Л.В., Дубцова Е.А., Агафонов М.А. Качество жизни больных хроническим панкреатитом с функциональной недостаточностью поджелудочной железы. ДокторРу. 2014; 91(3): 54 - 9,

126. Hammer H.F., Fox M.R., Keller J., Salvatore S., Basilisco G., Hammer J., et al. European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus. United European Gastroenterol J. 2022; 10(1): 15 - 40. doi: 10.1002/ueg2.12133

127. Rezaie A., Buresi M., Lembo A., Lin H., McCallum R., Rao S., et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017; 112(5): 775 - 84. doi: 10.1038/ajg.2017.46

128. Ивашкин В.Т., Медведев О.С., Полуэктова Е.А., Кудряцева А.В., Бахтогаримов И.Р., Карчевская А.Е. Прямые и косвенные методы изучения микробиоты человека. Рос журн гастроэнтерол гепатол колопроктол. 2022; 32(2): 19 - 34. doi: 10.22416/1382-4376-2022-32-2-19-34

129. Khoshini R., Dai S.C., Lezcano S., Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008; 53(6): 1443 - 54. doi: 10.1007/s10620-007-0065-1

130. Gullo L., Barbara L., Labo G. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology. 1988; 95(4): 1063 - 8, http://www.ncbi.nlm.nih.gov/pubmed/3410221

131. Hayakawa T., Kondo T., Shibata T., Sugimoto Y., Kitagawa M. Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis. Dig Dis Sci. 1989; 34(1): 33 - 8, http://www.ncbi.nlm.nih.gov/pubmed/2910680

132. Lankisch P.G., Seidensticker F., Lohr-Happe A., Otto J., Creutzfeldt W. The course of pain is the same in alcohol- and nonalcohol-induced chronic pancreatitis. Pancreas. 1995; 10(4): 338 - 41, http://www.ncbi.nlm.nih.gov/pubmed/7792289

133. Nakamura Y., Kobayashi Y., Ishikawa A., Maruyama K., Higuchi S. Severe chronic pancreatitis and severe liver cirrhosis have different frequencies and are independent risk factors in male Japanese alcoholics. J Gastroenterol. 2004; 39(9): 879 - 87. doi: 10.1007/s00535-004-1405-y

134. Ammann R.W., Heitz P.U., Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology. 1996; 111(1): 224 - 31, http://www.ncbi.nlm.nih.gov/pubmed/8698203

135. Cahen D.L., Gouma D.J., Nio Y., Rauws E.A., Boermeester M.A., Busch O.R., et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med. 2007; 356(7): 676 - 84. doi: 10.1056/NEJMoa060610

136. Witt H., Apte M.V., Keim V., Wilson J.S. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology. 2007; 132(4): 1557 - 73. doi: 10.1053/j.gastro.2007.03.001

137. Maisonneuve P., Lowenfels A.B., Mullhaupt B., Cavallini G., Lankisch P.G., Andersen J.R., et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut. 2005; 54(4): 510 - 4. doi: 10.1136/gut.2004.039263

138. Rothenbacher D., Low M., Hardt P.D., Klor H.U., Ziegler H., Brenner H. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol. 2005; 40(6): 697 - 704. doi: 10.1080/00365520510023116

139. Ивашкин В.Т., Шевченко В.П. Питание при болезнях органов пищеварения. Военно-медицинский журнал. 2006; 327(1): 54,

140. Scolapio J.S., Malhi-Chowla N., Ukleja A. Nutrition supplementation in patients with acute and chronic pancreatitis. Gastroenterol Clin North Am. 1999; 28(3): 695 - 707, http: //www.ncbi.nlm.nih.gov/pubmed/10503145

141. Sommer H., Kasper H. Effect of long-term administration of dietary fiber on the exocrine pancreas in the rat. Hepatogastroenterology. 1984; 31(4): 176 - 9, http: //www.ncbi.nlm.nih.gov/pubmed/6207085

142. Dutta S.K., Hlasko J. Dietary fiber in pancreatic disease: effect of high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr. 1985; 41(3): 517 - 25, http: //www.ncbi.nlm.nih.gov/pubmed/2579539

143. Dutta S.K., Bustin M.P., Russell R.M., Costa B.S. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med. 1982; 97(4): 549 - 52, http: //www.ncbi.nlm.nih.gov/pubmed/6922690

144. Moran C.E., Sosa E.G., Martinez S.M., Geldern P., Messina D., Russo A., et al. Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol. 1997; 92(5): 867 - 71, http: //www.ncbi.nlm.nih.gov/pubmed/9149203

145. Drewes A.M., Bouwense S.A.W., Campbell C.M., Ceyhan G.O., Delhaye M., Demir I.E., et al. Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology. 2017; 17(5): 720 - 31. doi: 10.1016/j.pan.2017.07.006

146. Bouwense S.A., Olesen S.S., Drewes A.M., Poley J.W., van Goor H., Wilder-Smith O.H. Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial. PLoS One. 2012; 7(8): e42096. doi: 10.1371/journal.pone.0042096

147. Olesen S.S., Bouwense S.A., Wilder-Smith O.H., van Goor H., Drewes A.M. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology. 2011; 141(2): 536 - 43. doi: 10.1053/j.gastro.2011.04.003

148. Yaghoobi M., McNabb-Baltar J., Bijarchi R., Cotton P.B. Pancreatic Enzyme Supplements Are Not Effective for Relieving Abdominal Pain in Patients with Chronic Pancreatitis: Meta-Analysis and Systematic Review of Randomized Controlled Trials. Can J Gastroenterol Hepatol. 2016; 2016: 8541839. doi: 10.1155/2016/8541839

149. Shafiq N., Rana S., Bhasin D., Pandhi P., Srivastava P., Sehmby S.S., et al. Pancreatic enzymes for chronic pancreatitis. Cochrane Database Syst Rev. 2009(4): CD006302. doi: 10.1002/14651858.CD006302.pub2

150. de la D., Huang W., Szatmary P., Baston-Rey I., Gonzalez-Lopez J., Prada-Ramallal G., et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut. 2017; 66(8): 1354 - 5. doi: 10.1136/gutjnl-2016-312529

151. Ивашкин В.Т., Охлобыстин А.В., Баярмаа Н. Эффективность микрокапсулированных ферментов, покрытых энтеросолюбильной оболочкой, при хроническом панкреатите//Клинические перспективы гастроэнтерологии, гепатологии. 2001(5): 15 - 9,

152. Dominguez-Munoz J.E. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep. 2007; 9(2): 116 - 22, http: //www.ncbi.nlm.nih.gov/pubmed/17418056

153. Matsumoto J., Traverso L.W. Exocrine function following the whipple operation as assessed by stool elastase. J Gastrointest Surg. 2006; 10(9): 1225 - 9. doi: 10.1016/j.gassur.2006.08.001

154. Dumasy V., Delhaye M., Cotton F., Deviere J. Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol. 2004; 99(7): 1350 - 4. doi: 10.1111/j.1572-0241.2004.30661.x

155. Waljee A.K., Dimagno M.J., Wu B.U., Schoenfeld P.S., Conwell D.L. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis. Aliment Pharmacol Ther. 2009; 29(3): 235 - 46. doi: 10.1111/j.1365-2036.2008.03885.x

156. de la Iglesia-Garcia D., Huang W., Szatmary P., Baston-Rey I., Gonzalez-Lopez J., Prada-Ramallal G., et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut. 2017; 66(8): 1354 - 5. doi: 10.1136/gutjnl-2016-312529

157. Phillips M.E., Robertson M.D., Hart K.H., Kumar R., Pencavel T.D. Long-term effects of clinical interventions on nutritional status in patients with chronic pancreatitis - A systematic review. Clin Nutr ESPEN. 2022; 48: 178 - 85. doi: 10.1016/j.clnesp.2021.12.032

158. Бидеева Т.В., Маев И.В., Кучерявый Ю.А., Андреев Д.Н., Шах Ю.С., Лобанова Е.Г., et al. Эффективность заместительной ферментной терапии с использованием микрокапсулированных препаратов панкреатина при коррекции нутритивного статуса у пациентов с хроническим панкреатитом: проспективное наблюдательное исследование. Тер арх. 2020; 92(1): 30 - 5. doi: 10.26442/00403660.2020.01.000488

159. Буклис Э.Р., Ивашкин В.Т. Хронический панкреатит: этиология, патофизиология и консервативная терапия. Рос журн гастроэнтерол гепатол колопроктол. 2006; 16(6): 79 - 86,

160. Маев И.В., Кучерявый Ю.А., Оганесян Т.С., Трошина И.В., Москалева А.Б., Устинова Н.Н., et al. Фармакоэкономическая эффективность заместительной терапии различными препаратами панкреатина у больных хроническим панкреатитом с экзокринной панкреатической недостаточностью. Фарматека. 2010(15): 98 - 104,

161. Маев И.В., Свиридова А.В., Кучерявый Ю.А. Длительная заместительная ферментная терапия различными препаратами панкреатина у больных хроническим панкреатитом с экзокринной недостаточностью поджелудочной железы Фарматека. 2011(2): 32 - 9,

162. Czako L., Takacs T., Hegyi P., Pronai L., Tulassay Z., Lakner L., et al. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol. 2003; 17(10): 597 - 603, http: //www.ncbi.nlm.nih.gov/pubmed/14571298

163. Dominguez-Munoz J.E., Iglesias-Garcia J., Iglesias-Rey M., Figueiras A., Vilarino-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther. 2005; 21(8): 993 - 1000. doi: 10.1111/j.1365-2036.2005.02390.x

164. Thorat V., Reddy N., Bhatia S., Bapaye A., Rajkumar J.S., Kini D.D., et al. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2012; 36(5): 426 - 36. doi: 10.1111/j.1365-2036.2012.05202.x

165. Whitcomb D.C., Lehman G.A., Vasileva G., Malecka-Panas E., Gubergrits N., Shen Y., et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol. 2010; 105(10): 2276 - 86. doi: 10.1038/ajg.2010.201

166. Ramesh H., Reddy N., Bhatia S., Rajkumar J.S., Bapaye A., Kini D., et al. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013; 13(2): 133 - 9. doi: 10.1016/j.pan.2013.01.009

167. Krishnamurty D.M., Rabiee A., Jagannath S.B., Andersen D.K. Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis. Ther Clin Risk Manag. 2009; 5(3): 507 - 20, http: //www.ncbi.nlm.nih.gov/pubmed/19707261

168. Brennan G.T., Saif M.W. Pancreatic Enzyme Replacement Therapy: A Concise Review. Jop. 2019; 20(5): 121 - 5,

169. Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol. 2013; 19(42): 7258 - 66. doi: 10.3748/wjg.v19.i42.7258

170. Dominguez-Munoz J.E., Drewes A.M., Lindkvist B., Ewald N., Czako L., Rosendahl J., et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology. 2018; 18(8): 847 - 54. doi: 10.1016/j.pan.2018.09.016

171. Кучерявый Ю.А. Оценка эффективности комбинированной антисекреторной и полиферментной терапии при хроническом панкреатите с тяжелой внешнесекреторной недостаточностью. Рос журн гастроэнтерол гепатол колопроктол. 2004(2): 78 - 83,

172. Dominguez-Munoz J.E., Iglesias-Garcia J., Iglesias-Rey M., Vilarino-Insua M. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut. 2006; 55(7): 1056 - 7. doi: 10.1136/gut.2006.094912

173. Phillips M.E., Hopper A.D., Leeds J.S., Roberts K.J., McGeeney L., Duggan S.N., et al. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterol. 2021; 8(1). doi: 10.1136/bmjgast-2021-000643

174. Кучерявый Ю.А. Опыт применения эзомепразола в комплексной терапии обострения хронического панкреатита Клинические перспективы гастроэнтерологии, гепатологии. 2005(6): 35 - 41,

175. Damborg F., Damborg S.B., Schaffalitzky de Muckadell O.B. [Does intake of gastric acid pump inhibitor affect the evaluation of the Lundh test?]. Ugeskr Laeger. 2002; 164(35): 4070 - 3, http: //www.ncbi.nlm.nih.gov/pubmed/12229307

176. Mancilla A.C., Madrid S.A., Hurtado H.C., Orellana B.C., Pena Z.M., Tobar A.E., et al. [Small intestine bacterial overgrowth in patients with chronic pancreatitis]. Rev Med Chil. 2008; 136(8): 976 - 80. doi: /S0034 - 98872008000800003

177. Achufusi T.G.O., Sharma A., Zamora E.A., Manocha D. Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods. Cureus. 2020; 12(6): e8860. doi: 10.7759/cureus.8860

178. Goldenberg J.Z., Yap C., Lytvyn L., Lo C.K., Beardsley J., Mertz D., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017; 12(12): CD006095. doi: 10.1002/14651858.CD006095.pub4

179. Goodman C., Keating G., Georgousopoulou E., Hespe C., Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021; 11(8): e043054. doi: 10.1136/bmjopen-2020-043054

180. Ивашкин В.Т., Маев И.В., Абдулганиева Д.И., Алексеенко С.А., Горелов А.В., Захарова И.Н., et al. Практические рекомендации Научного сообщества по содействию клиническому изучению микробиома человека (НСОИМ) и Российской гастроэнтерологической ассоциации (РГА) по применению пробиотиков, пребиотиков, синбиотиков и обогащенных ими функциональных пищевых продуктов для лечения и профилактики заболеваний гастроэнтерологического профиля у детей и взрослых. Рос журн гастроэнтерол гепатол колопроктол. 2021; 31(2): 65 - 91. doi: 10.22416/1382-4376-2021-31-2-65-91

181. Okazaki K., Chari S.T., Frulloni L., Lerch M.M., Kamisawa T., Kawa S., et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017; 17(1): 1 - 6. doi: 10.1016/j.pan.2016.12.003

182. Лер Й., Бойерс У., Вуясинович М., Альваро Д., Фрекьер Й.Б., Ботгрид Ф., et al. Европейские рекомендации по IgG4-ассоциированным заболеваниям в гастроэнтерологии - рекомендации UEG и SGF, основанные на доказательствах. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021; 31(1): 34,

183. Maire F., Le Baleur Y., Rebours V., Vullierme M.P., Couvelard A., Voitot H., et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011; 106(1): 151 - 6. doi: 10.1038/ajg.2010.314

184. Hart P.A., Kamisawa T., Brugge W.R., Chung J.B., Culver E.L., Czako L., et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013; 62(12): 1771 - 6. doi: 10.1136/gutjnl-2012-303617

185. Kubota K., Iida H., Fujisawa T., Yoneda M., Inamori M., Abe Y., et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007; 66(6): 1142 - 51. doi: 10.1016/j.gie.2007.06.059

186. Topazian M., Witzig T.E., Smyrk T.C., Pulido J.S., Levy M.J., Kamath P.S., et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2008; 6(3): 364 - 6. doi: 10.1016/j.cgh.2007.12.020

187. Kamisawa T., Yoshiike M., Egawa N., Nakajima H., Tsuruta K., Okamoto A. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology. 2005; 5(2 - 3): 234 - 8; discussion 8 - 40. doi: 10.1159/000085277

188. Hart P.A., Topazian M.D., Witzig T.E., Clain J.E., Gleeson F.C., Klebig R.R., et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013; 62(11): 1607 - 15. doi: 10.1136/gutjnl-2012-302886

189. Moon S.H., Kim M.H., Park D.H., Hwang C.Y., Park S.J., Lee S.S., et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut. 2008; 57(12): 1704 - 12. doi: 10.1136/gut.2008.150979

190. Tacelli M., Celsa C., Magro B., Barresi L., Guastella S., Capurso G., et al. Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019; 17(6): 1061 - 72 e8. doi: 10.1016/j.cgh.2018.09.051

191. Masamune A., Nishimori I., Kikuta K., Tsuji I., Mizuno N., Iiyama T., et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017; 66(3): 487 - 94. doi: 10.1136/gutjnl-2016-312049

192. Kubota K., Kamisawa T., Okazaki K., Kawa S., Hirano K., Hirooka Y., et al. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients. J Gastroenterol. 2017; 52(8): 955 - 64. doi: 10.1007/s00535-016-1302-1

193. Tacelli M., Celsa C., Magro B., Barresi L., Guastella S., Capurso G., et al. Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019; 17(6): 1061 - 72.e8. doi: 10.1016/j.cgh.2018.09.051

194. Kempeneers M.A., Besselink M.G., Issa Y., van Hooft J.E., van Goor H., Bruno M.J., et al. [Multidisciplinary treatment of chronic pancreatitis: an overview of current step-up approach and new options]. Ned Tijdschr Geneeskd. 2017; 161: D1454, http: //www.ncbi.nlm.nih.gov/pubmed/28984211

195. D"Haese J.G., Ceyhan G.O., Demir I.E., Tieftrunk E., Friess H. Treatment options in painful chronic pancreatitis: a systematic review. HPB (Oxford). 2014; 16(6): 512 - 21. doi: 10.1111/hpb.12173

196. Skube M.E., Beilman G.J. Surgical treatment of pain in chronic pancreatitis. Curr Opin Gastroenterol. 2018; 34(5): 317 - 21. doi: 10.1097/MOG.0000000000000460

197. Tillou J.D., Tatum J.A., Jolissaint J.S., Strand D.S., Wang A.Y., Zaydfudim V., et al. Operative management of chronic pancreatitis: A review. Am J Surg. 2017; 214(2): 347 - 57. doi: 10.1016/j.amjsurg.2017.03.004

198. Jawad Z.A.R., Kyriakides C., Pai M., Wadsworth C., Westaby D., Vlavianos P., et al. Surgery remains the best option for the management of pain in patients with chronic pancreatitis: A systematic review and meta-analysis. Asian J Surg. 2017; 40(3): 179 - 85. doi: 10.1016/j.asjsur.2015.09.005

199. Bivins B.A., Bell R.M., Rapp R.P., Toedebusch W.H. Pancreatic exocrine response to parenteral nutrition. JPEN J Parenter Enteral Nutr. 1984; 8(1): 34 - 6. doi: 10.1177/014860718400800134

200. Pederzoli P., Bassi C., Falconi M., Albrigo R., Vantini I., Micciolo R. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gynecol Obstet. 1986; 163(5): 428 - 32, http: //www.ncbi.nlm.nih.gov/pubmed/2877505

201. de Castro S.M., Busch O.R., Gouma D.J. Management of bleeding and leakage after pancreatic surgery. Best Pract Res Clin Gastroenterol. 2004; 18(5): 847 - 64. doi: 10.1016/j.bpg.2004.06.001

202. Jawad Z.A.R., Tsim N., Pai M., Bansi D., Westaby D., Vlavianos P., et al. Short and long-term post-operative outcomes of duodenum preserving pancreatic head resection for chronic pancreatitis affecting the head of pancreas: a systematic review and meta-analysis. HPB (Oxford). 2016; 18(2): 121 - 8. doi: 10.1016/j.hpb.2015.10.003

203. Nealon W.H., Walser E. Duct drainage alone is sufficient in the operative management of pancreatic pseudocyst in patients with chronic pancreatitis. Ann Surg. 2003; 237(5): 614 - 20; discussion 20 - 2. doi: 10.1097/01.SLA.0000064360.14269.EF

204. Arslanlar S., Jain R. Benign biliary strictures related to chronic pancreatitis: balloons, stents, or surgery. Curr Treat Options Gastroenterol. 2007; 10(5): 369 - 75, http: //www.ncbi.nlm.nih.gov/pubmed/17897575

205. Кригер А.Г. Хирургическая панкреатология. М.: РИА "Внешторгиздат"; 2021. 332 p.

206. Farkas G., Leindler L., Daroczi M., Farkas G., Jr. Prospective randomised comparison of organ-preserving pancreatic head resection with pylorus-preserving pancreaticoduodenectomy. Langenbecks Arch Surg. 2006; 391(4): 338 - 42. doi: 10.1007/s00423-006-0051-7

207. Lu W.P., Shi Q., Zhang W.Z., Cai S.W., Jiang K., Dong J.H. A meta-analysis of the long-term effects of chronic pancreatitis surgical treatments: duodenum-preserving pancreatic head resection versus pancreatoduodenectomy. Chin Med J (Engl). 2013; 126(1): 147 - 53, http: //www.ncbi.nlm.nih.gov/pubmed/23286494

208. Yin Z., Sun J., Yin D., Wang J. Surgical treatment strategies in chronic pancreatitis: a meta-analysis. Arch Surg. 2012; 147(10): 961 - 8. doi: 10.1001/archsurg.2012.2005

209. Buchler M.W., Friess H., Muller M.W., Wheatley A.M., Beger H.G. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg. 1995; 169(1): 65 - 9; discussion 9 - 70, http: //www.ncbi.nlm.nih.gov/pubmed/7818000

210. Dite P., Ruzicka M., Zboril V., Novotny I. A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis. Endoscopy. 2003; 35(7): 553 - 8. doi: 10.1055/s-2003-40237

211. Izbicki J.R., Bloechle C., Knoefel W.T., Kuechler T., Binmoeller K.F., Soehendra N., et al. [Drainage versus resection in surgical therapy of chronic pancreatitis of the head of the pancreas: a randomized study]. Chirurg. 1997; 68(4): 369 - 77, http: //www.ncbi.nlm.nih.gov/pubmed/9206631

212. Izbicki J.R., Bloechle C., Broering D.C., Knoefel W.T., Kuechler T., Broelsch C.E. Extended drainage versus resection in surgery for chronic pancreatitis: a prospective randomized trial comparing the longitudinal pancreaticojejunostomy combined with local pancreatic head excision with the pylorus-preserving pancreatoduodenectomy. Ann Surg. 1998; 228(6): 771 - 9, http: //www.ncbi.nlm.nih.gov/pubmed/9860476

213. Klempa I., Spatny M., Menzel J., Baca I., Nustede R., Stockmann F., et al. [Pancreatic function and quality of life after resection of the head of the pancreas in chronic pancreatitis. A prospective, randomized comparative study after duodenum preserving resection of the head of the pancreas versus Whipple"s operation]. Chirurg. 1995; 66(4): 350 - 9, http: //www.ncbi.nlm.nih.gov/pubmed/7634946

214. Sakorafas G.H., Sarr M.G. Pancreatic cancer after surgery for chronic pancreatitis. Dig Liver Dis. 2003; 35(7): 482 - 5, http: //www.ncbi.nlm.nih.gov/pubmed/12870734

215. Dumonceau J.M., Deviere J., Le Moine O., Delhaye M., Vandermeeren A., Baize M., et al. Endoscopic pancreatic drainage in chronic pancreatitis associated with ductal stones: long-term results. Gastrointest Endosc. 1996; 43(6): 547 - 55, http: //www.ncbi.nlm.nih.gov/pubmed/8781931

216. Gabbrielli A., Pandolfi M., Mutignani M., Spada C., Perri V., Petruzziello L., et al. Efficacy of main pancreatic-duct endoscopic drainage in patients with chronic pancreatitis, continuous pain, and dilated duct. Gastrointest Endosc. 2005; 61(4): 576 - 81, http: //www.ncbi.nlm.nih.gov/pubmed/15812411

217. Dumonceau J.M., Delhaye M., Tringali A., Arvanitakis M., Sanchez-Yague A., Vaysse T., et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated August 2018. Endoscopy. 2019; 51(2): 179 - 93. doi: 10.1055/a-0822-0832

218. Li B.R., Liao Z., Du T.T., Ye B., Chen H., Ji J.T., et al. Extracorporeal shock wave lithotripsy is a safe and effective treatment for pancreatic stones coexisting with pancreatic pseudocysts. Gastrointest Endosc. 2016; 84(1): 69 - 78. doi: 10.1016/j.gie.2015.10.026

219. Hodo Y., Shirota Y., Suda T., Wakabayashi T. Transcatheter pancreatoscopy-guided electrohydraulic lithotripsy for large pancreatic duct stones. Endoscopy. 2017; 49(6): E147 - E8. doi: 10.1055/s-0043-105575

220. Goodchild G., Sivalokanathan S., Webster G. Cholangioscopy and electrohydraulic lithotripsy in the management of fistulated pancreatic duct stones. Endoscopy. 2018; 50(7): E163 - E4. doi: 10.1055/a-0599-0280

221. Novikov A., Xu M.M., Tyberg A., Kahaleh M. Endoscopic management of chronic pancreatitis with a fully covered self-expanding metal stent and laser lithotripsy. Endoscopy. 2017; 49(12): E296 - E7. doi: 10.1055/s-0043-118214

222. Heyries L., Sahel J. Endoscopic treatment of chronic pancreatitis. World J Gastroenterol. 2007; 13(46): 6127 - 33. doi: 10.3748/wjg.v13.i46.6127

223. Eleftherladis N., Dinu F., Delhaye M., Le Moine O., Baize M., Vandermeeren A., et al. Long-term outcome after pancreatic stenting in severe chronic pancreatitis. Endoscopy. 2005; 37(3): 223 - 30. doi: 10.1055/s-2005-860988

224. Testoni P.A. Endoscopic stenting in benign pancreatic diseases. JOP. 2007; 8(1 Suppl): 141 - 50, http: //www.ncbi.nlm.nih.gov/pubmed/17228146

225. Ponchon T., Bory R.M., Hedelius F., Roubein L.D., Paliard P., Napoleon B., et al. Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol. Gastrointest Endosc. 1995; 42(5): 452 - 6, http: //www.ncbi.nlm.nih.gov/pubmed/8566637

226. Costamagna G., Bulajic M., Tringali A., Pandolfi M., Gabbrielli A., Spada C., et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy. 2006; 38(3): 254 - 9. doi: 10.1055/s-2005-921069

227. Kahl S., Zimmermann S., Genz I., Glasbrenner B., Pross M., Schulz H.U., et al. Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am J Gastroenterol. 2003; 98(11): 2448 - 53. doi: 10.1111/j.1572-0241.2003.08667.x

228. Pozsar J., Sahin P., Laszlo F., Forro G., Topa L. Medium-term results of endoscopic treatment of common bile duct strictures in chronic calcifying pancreatitis with increasing numbers of stents. J Clin Gastroenterol. 2004; 38(2): 118 - 23, http: //www.ncbi.nlm.nih.gov/pubmed/14745285

229. Hughes D.L., Hughes I., Silva M.A. A meta-analysis of the long-term outcomes following surgery or endoscopic therapy for chronic pancreatitis. Langenbecks Arch Surg. 2022; 407(6): 2233 - 45. doi: 10.1007/s00423-022-02468-x

230. Boregowda U., Echavarria J., Umapathy C., Rosenkranz L., Sayana H., Patel S., et al. Endoscopy versus early surgery for the management of chronic pancreatitis: a systematic review and meta-analysis. Surg Endosc. 2022; 36(12): 8753 - 63. doi: 10.1007/s00464-022-09425-1

231. Mendieta P.J.O., Sagae V.M.T., Ribeiro I.B., de Moura D.T.H., Scatimburgo M., Hirsch B.S., et al. Pain relief in chronic pancreatitis: endoscopic or surgical treatment? a systematic review with meta-analysis. Surg Endosc. 2021; 35(8): 4085 - 94. doi: 10.1007/s00464-021-08515-w

232. Committee A.S.o.P., Chandrasekhara V., Chathadi K.V., Acosta R.D., Decker G.A., Early D.S., et al. The role of endoscopy in benign pancreatic disease. Gastrointest Endosc. 2015; 82(2): 203 - 14. doi: 10.1016/j.gie.2015.04.022

233. Chebli J.M., Gaburri P.D., de Souza A.F., Ornellas A.T., Martins Junior E.V., Chebli L.A., et al. Internal pancreatic fistulas: proposal of a management algorithm based on a case series analysis. J Clin Gastroenterol. 2004; 38(9): 795 - 800. doi: 10.1097/01.mcg.0000139051.74801.43

234. Lerch M.M., Stier A., Wahnschaffe U., Mayerle J. Pancreatic pseudocysts: observation, endoscopic drainage, or resection? Dtsch Arztebl Int. 2009; 106(38): 614 - 21. doi: 10.3238/arztebl.2009.0614

235. Morton J.M., Brown A., Galanko J.A., Norton J.A., Grimm I.S., Behrns K.E. A national comparison of surgical versus percutaneous drainage of pancreatic pseudocysts: 1997 - 2001. J Gastrointest Surg. 2005; 9(1): 15 - 20; discussion -1. doi: 10.1016/j.gassur.2004.10.005

236. Kleeff J., Stoss C., Mayerle J., Stecher L., Maak M., Simon P., et al. Evidence-Based Surgical Treatments for Chronic Pancreatitis. Dtsch Arztebl Int. 2016; 113(29 - 30): 489 - 96. doi: 10.3238/arztebl.2016.0489

237. Kozarek R.A., Ball T.J., Patterson D.J., Raltz S.L., Traverso L.W., Ryan J.A., et al. Transpapillary stenting for pancreaticocutaneous fistulas. J Gastrointest Surg. 1997; 1(4): 357 - 61. doi: 10.1016/s1091-255x(97)80057-1

238. Haapamaki C., Kylanpaa L., Udd M., Lindstrom O., Gronroos J., Saarela A., et al. Randomized multicenter study of multiple plastic stents vs. covered self-expandable metallic stent in the treatment of biliary stricture in chronic pancreatitis. Endoscopy. 2015; 47(7): 605 - 10. doi: 10.1055/s-0034-1391331

239. Frey C.F., Amikura K. Local resection of the head of the pancreas combined with longitudinal pancreaticojejunostomy in the management of patients with chronic pancreatitis. Ann Surg. 1994; 220(4): 492 - 504; discussion -7. doi: 10.1007/bf02348284

240. Gloor B., Friess H., Uhl W., Buchler M.W. A modified technique of the Beger and Frey procedure in patients with chronic pancreatitis. Dig Surg. 2001; 18(1): 21 - 5. doi: 10.1159/000050092

241. Frey C.F., Mayer K.L. Comparison of local resection of the head of the pancreas combined with longitudinal pancreaticojejunostomy (frey procedure) and duodenum-preserving resection of the pancreatic head (beger procedure). World J Surg. 2003; 27(11): 1217 - 30. doi: 10.1007/s00268-003-7241-z

242. Strobel O., Buchler M.W., Werner J. [Duodenum-preserving pancreatic head resection: technique according to Beger, technique according to Frey and Berne modifications]. Chirurg. 2009; 80(1): 22 - 7. doi: 10.1007/s00104-008-1577-8

243. Sukharamwala P.B., Patel K.D., Teta A.F., Parikh S., Ross S.B., Ryan C.E., et al. Long-term Outcomes Favor Duodenum-preserving Pancreatic Head Resection over Pylorus-preserving Pancreaticoduodenectomy for Chronic Pancreatitis: A Meta-analysis and Systematic Review. Am Surg. 2015; 81(9): 909 - 14, http: //www.ncbi.nlm.nih.gov/pubmed/26350671

244. Aguilera F., Tsamalaidze L., Raimondo M., Puri R., Asbun H.J., Stauffer J.A. Pancreaticoduodenectomy and Outcomes for Groove Pancreatitis. Dig Surg. 2018; 35(6): 475 - 81. doi: 10.1159/000485849

245. Witzigmann H., Max D., Uhlmann D., Geissler F., Schwarz R., Ludwig S., et al. Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery. 2003; 134(1): 53 - 62. doi: 10.1067/msy.2003.170

246. Fankhauser G.T., Stone W.M., Naidu S.G., Oderich G.S., Ricotta J.J., Bjarnason H., et al. The minimally invasive management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg. 2011; 53(4): 966 - 70. doi: 10.1016/j.jvs.2010.10.071

247. De Rosa A., Gomez D., Pollock J.G., Bungay P., De Nunzio M., Hall R.I., et al. The radiological management of pseudoaneurysms complicating pancreatitis. JOP. 2012; 13(6): 660 - 6. doi: 10.6092/1590-8577/1193

248. Кригер А.Г., Кубышкин В.А., Кармазановский Г.Г., соавт. и. Послеоперационный панкреатит при хирургических вмешательствах на поджелудочной железе..;:. Хирургия Журнал им НИ Пирогова. 2012(4): 14 - 9,

249. Connor S. Defining post-operative pancreatitis as a new pancreatic specific complication following pancreatic resection. HPB (Oxford). 2016; 18(8): 642 - 51. doi: 10.1016/j.hpb.2016.05.006

250. Hu Y., Xiong W., Li C., Cui Y. Continuous blood purification for severe acute pancreatitis: A systematic review and meta-analysis. Medicine (Baltimore). 2019; 98(12): e14873. doi: 10.1097/MD.0000000000014873

251. Li-Ling J., Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg. 2001; 88(2): 190 - 9. doi: 10.1046/j.1365-2168.2001.01659.x

252. Pulvirenti A., Ramera M., Bassi C. Modifications in the International Study Group for Pancreatic Surgery (ISGPS) definition of postoperative pancreatic fistula. Transl Gastroenterol Hepatol. 2017; 2: 107. doi: 10.21037/tgh.2017.11.14

253. Bassi C., Marchegiani G., Dervenis C., Sarr M., Abu Hilal M., Adham M., et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017; 161(3): 584 - 91. doi: 10.1016/j.surg.2016.11.014

254. Wente M.N., Veit J.A., Bassi C., Dervenis C., Fingerhut A., Gouma D.J., et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007; 142(1): 20 - 5. doi: 10.1016/j.surg.2007.02.001

255. Roulin D., Cerantola Y., Demartines N., Schafer M. Systematic review of delayed postoperative hemorrhage after pancreatic resection. J Gastrointest Surg. 2011; 15(6): 1055 - 62. doi: 10.1007/s11605-011-1427-8

256. Potrc S., Ivanecz A., Pivec V., Marolt U., Rudolf S., Iljevec B., et al. Impact Factors for Perioperative Morbidity and Mortality and Repercussion of Perioperative Morbidity and Long-term Survival in Pancreatic Head Resection. Radiol Oncol. 2018; 52(1): 54 - 64. doi: 10.1515/raon-2017-0036

257. Koukoutsis I., Bellagamba R., Morris-Stiff G., Wickremesekera S., Coldham C., Wigmore S.J., et al. Haemorrhage following pancreaticoduodenectomy: risk factors and the importance of sentinel bleed. Dig Surg. 2006; 23(4): 224 - 8. doi: 10.1159/000094754

258. Choi S.H., Moon H.J., Heo J.S., Joh J.W., Kim Y.I. Delayed hemorrhage after pancreaticoduodenectomy. J Am Coll Surg. 2004; 199(2): 186 - 91. doi: 10.1016/j.jamcollsurg.2004.04.005

259. Yekebas E.F., Wolfram L., Cataldegirmen G., Habermann C.R., Bogoevski D., Koenig A.M., et al. Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections. Ann Surg. 2007; 246(2): 269 - 80. doi: 10.1097/01.sla.0000262953.77735.db

260. Кригер А.Г., Горин Д.С., Гоев А.А., Варава А.Б., Берелавичус С.В., Ахтанин Е.А. Послеоперационное кровотечение в хирургии поджелудочной железы. Анналы хирургической гепатологии. 2017; 22(2): 36 - 44. doi: https://doi.org/10.16931/1995-5464.2017236-44

261. Brown A., Hughes M., Tenner S., Banks P.A. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am J Gastroenterol. 1997; 92(11): 2032 - 5, http: //www.ncbi.nlm.nih.gov/pubmed/9362186

262. Шифрин О.С., Ивашкин В.Т. Роль ферментных препаратов в лечении пациентов с болевой формой хронического панкреатита. Клинические перспективы гастроэнтерологии, гепатологии. 2009(3): 3 - 8,

263. Белоусова Е.А., Никитина Н.В., Цодиков Г.В. Оптимизация схем лечения хронического панкреатита ферментными препаратами. Фарматека. 2008(13): 103 - 8,

264. Маев И.В., Кучерявый Ю.А., Свиридова А.В., Самсонов А.А., Оганесян Т.С., Казюлин А.Н., et al. Эффективность лечения внешнесекреторной недостаточности поджелудочной железы различными препаратами панкреатина. Клинические перспективы гастроэнтерологии, гепатологии. 2010(6): 29 - 37,

265. Pujahari A.K. A Novel Method for Pain Relief in Chronic Pancreatitis: an Old Drug in a New Pack: a Controlled Study. Indian J Surg. 2017; 79(6): 549 - 54. doi: 10.1007/s12262-016-1526-6

266. Delhaye M., Meuris S., Gohimont A.C., Buedts K., Cremer M. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Eur J Gastroenterol Hepatol. 1996; 8(7): 699 - 703,

267. Lowenfels A.B., Maisonneuve P., Cavallini G., Ammann R.W., Lankisch P.G., Andersen J.R., et al. Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group. Am J Gastroenterol. 1994; 89(9): 1467 - 71, http: //www.ncbi.nlm.nih.gov/pubmed/8079921

268. Ito T., Ishiguro H., Ohara H., Kamisawa T., Sakagami J., Sata N., et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol. 2016; 51(2): 85 - 92. doi: 10.1007/s00535-015-1149-x

269. Makar M., Worple E., Dove J., Hunsinger M., Arora T., Oxenberg J., et al. Disparities in Care: Impact of Socioeconomic Factors on Pancreatic Surgery: Exploring the National Cancer Database. Am Surg. 2019; 85(4): 327 - 34, http: //www.ncbi.nlm.nih.gov/pubmed/31043190

270. Xiong J., Szatmary P., Huang W., de la Iglesia-Garcia D., Nunes Q.M., Xia Q., et al. Enhanced Recovery After Surgery Program in Patients Undergoing Pancreaticoduodenectomy: A PRISMA-Compliant Systematic Review and Meta-Analysis. Medicine (Baltimore). 2016; 95(18): e3497. doi: 10.1097/MD.0000000000003497

271. Brown E.G., Bateni S.B., Burgess D., Li C.S., Bold R.J. Interhospital Variability in Quality Outcomes of Pancreatic Surgery. J Surg Res. 2019; 235: 453 - 8. doi: 10.1016/j.jss.2018.10.035

272. Есаков Ю.С., Раевская М.Б., Сизов В.А., Печетов А.А., Ручкин Д.В., Горин Д.С., et al. Философия ускоренной реабилитации в торакоабдоминальной хирургии. Хирургия Журнал им НИ Пирогова. 2016(11): 88 - 92. doi: https://doi.org/10.17116/hirurgia20161188-92

273. Ammann R.W., Muellhaupt B. Progression of alcoholic acute to chronic pancreatitis. Gut. 1994; 35(4): 552 - 6, http: //www.ncbi.nlm.nih.gov/pubmed/8174996

274. Rasmussen M.S., Jorgensen L.N., Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009(1): CD004318. doi: 10.1002/14651858.CD004318.pub2

275. Suchsland T., Aghdassi A., Kuhn K., Simon P., Lerch M.M., Mayerle J., et al. Predictive factors for and incidence of hospital readmissions of patients with acute and chronic pancreatitis. Pancreatology. 2015; 15(3): 265 - 70. doi: 10.1016/j.pan.2015.03.008

276. Ahmed Ali U., Nieuwenhuijs V.B., van Eijck C.H., Gooszen H.G., van Dam R.M., Busch O.R., et al. Clinical outcome in relation to timing of surgery in chronic pancreatitis: a nomogram to predict pain relief. Arch Surg. 2012; 147(10): 925 - 32. doi: 10.1001/archsurg.2012.1094

277. Beyer G., Mahajan U.M., Budde C., Bulla T.J., Kohlmann T., Kuhlmann L., et al. Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts. Gastroenterology. 2017; 153(6): 1544 - 54 e2. doi: 10.1053/j.gastro.2017.08.073

278. Lin Y.C., Kor C.T., Su W.W., Hsu Y.C. Risk factors and prediction score for chronic pancreatitis: A nationwide population-based cohort study. World J Gastroenterol. 2018; 24(44): 5034 - 45. doi: 10.3748/wjg.v24.i44.5034

279. Patton R., Hilton C., Crawford M.J., Touquet R. The Paddington Alcohol Test: a short report. Alcohol Alcohol. 2004; 39(3): 266 - 8, http: //www.ncbi.nlm.nih.gov/pubmed/15082467

280. Wehler M., Reulbach U., Nichterlein R., Lange K., Fischer B., Farnbacher M., et al. Health-related quality of life in chronic pancreatitis: a psychometric assessment. Scand J Gastroenterol. 2003; 38(10): 1083 - 9. doi: 10.1080/00365520310005956

281. Мороз Е.В., Каратеев А.Е., Крюков Е.В. Хроническая абдоминальная боль при хроническом панкреатите: патогенез, клинические фенотипы и современная концепция терапии. Российский журнал боли. 2020; 18(2): 40 - 46. https://doi.org/10.17116/pain20201802140

282. Topazian M., Witzig T.E., Smyrk T.C., Pulido J.S., Levy M.J., Kamath P.S., et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2008; 6(3): 364 - 6. doi: 10.1016/j.cgh.2007.12.020

283. Khosroshahi A., Bloch D.B., Deshpande V., Stone J.H. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010; 62(6): 1755 - 62. doi: 10.1002/art.27435

284. Hart P.A., Topazian M.D., Witzig T.E., Clain J.E., Gleeson F.C., Klebig R.R., et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013; 62(11): 1607 - 15. doi: 10.1136/gutjnl-2012-302886

285. P., Kostov B., Bosch X., Acar-Denizli N., Ramos-Casals M., Stone J.H. Therapeutic approach to IgG4-related disease: A systematic review. Medicine (Baltimore). 2016; 95(26): e4002. doi: 10.1097/md.0000000000004002

286. Beaugerie L., Brousse N., Bouvier A.M., Colombel J.F., M., Cosnes J., et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009; 374(9701): 1617 - 25. doi: 10.1016/s0140-6736(09)61302-7

287. Yunyun F., Yu P., Panpan Z., Xia Z., Linyi P., Jiaxin Z., et al. Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial. Rheumatology (Oxford). 2019; 58(1): 52 - 60. doi: 10.1093/rheumatology/key227

288. Rovati L., Lanzillotta M., Bozzolo E., Arcidiacono P.G., Falconi M., Dagna L., et al. Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis. Am J Gastroenterol. 2019; 114(5): 831 - 3. doi: 10.14309/ajg.0000000000000232

289. Della-Torre E., Campochiaro C., Bozzolo E.P., Dagna L., Scotti R., Nicoletti R., et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford). 2015; 54(10): 1934 - 6. doi: 10.1093/rheumatology/kev244